Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications | Page 17
TABLE OF CONTENTS
14
COMPANY PROFILES...............................................................................................................139
•
(Overview, Financials, Products & Services, Strategy, & Developments)*
• 14.1 INTRODUCTION.............................................................................................................................................................139
• 14.2
B. BRAUN MELSUNGEN AG...........................................................................................................................................143
• 14.3
BECTON, DICKINSON AND COMPANY..........................................................................................................................145
• 14.4
BIOCON LIMITED...........................................................................................................................................................148
• 14.5
BIODEL INC....................................................................................................................................................................151
• 14.6
ELI LILLY AND COMPANY..............................................................................................................................................152
• 14.7
JULPHAR (ALSO KNOWN AS GULF PHARMACEUTICAL INDUSTRIES)........................................................................158
• 14.8
NOVO NORDISK A/S......................................................................................................................................................160
• 14.9 SANOFI.............. .............................................................................................................................................................166
• 14.10 WOCKHARDT LIMITED..................................................................................................................................................170
• 14.11 YPSOMED AG................................................................................................................................................................172
•
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
15 APPENDIX................................................................................................................................175
• 15.1 INSIGHTS OF INDUSTRY EXPERTS...............................................................................................................................175
• 15.2 DISCUSSION GUIDE......................................................................................................................................................176
• 15.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE..............................................................................................181
• 15.4 AVAILABLE CUSTOMIZATIONS......................................................................................................................................181
• 15.5 RELATED REPORTS........................................................................................................................................................182
•
[email protected]
www.marketsandmarkets.com
17